Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania
- PMID: 34097715
- PMCID: PMC8183982
- DOI: 10.1371/journal.pone.0252808
Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania
Abstract
Background: The prevalence of latent tuberculosis infection (LTBI) is vastly higher than that of tuberculosis (TB) disease and this enormous reservoir of individuals with LTBI impacts the global TB control strategy. Adolescents are at greatest risk of TB infection and are thus an ideal target population for a potential effective TB vaccine to be added to the current BCG programme as it could reduce the number of latent infections and consequently the number of adults with TB disease. However, LTBI rates are often unknown for this population. This study aims to estimate the magnitude of LTBI and to determine if Tanzanian adolescents would be a good population for a prevention of TB infection trial.
Methods: This was a descriptive cross-sectional study that recruited 193 adolescents aged 12 and 16 years from government schools and directly from the community in Mwanza Region, Tanzania. Socio-demographic characteristics were collected for all enrolled participants. Blood was drawn and tested using QuantiFERON-TB Gold In-Tube (QFT-GIT), and Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay (ESAT-6 free IGRA). Concordance between QFT-GIT and ESAT-6 free IGRA was evaluated using the McNemar's test.
Results: Overall estimates of LTBI prevalence were 19.2% [95%CI, 14.1; 25.2] and 18.6% [95%CI, 13.6; 24.6] as measured by QFT-GIT IGRA and ESAT-6 free IGRA, respectively. The 16-year-old cohort had a higher LTBI prevalence (23.7% [95%CI, 16.1; 32.9]) as compared to 12-year-old cohort (14.6% [95%CI, 8.6; 22.7]) as measured by QFT-GIT IGRA. When measured by ESAT-6 Free IGRA, LTBI prevalence was 24.7% (95%CI, 16.9; 34.0) for the 16-year-old cohort and 12.5% (95%CI, 7.0; 20.3) among the 12-year-old cohort. According to both tests the prevalence of TB infection and the corresponding annual risk of tuberculosis infection (ARTI) and force of infection were high and increased with age. Of all enrolled participants, 97.4% had concordant results for QFT-GIT IGRA and ESAT-6 free IGRA (p = 0.65).
Conclusions: The prevalence of LTBI and the associated ARTI and force of infection among adolescents is high and increases with age in Mwanza Region. There was a high concordance between the QFT-GIT and the novel ESAT-6 free IGRA assays. These findings suggest Mwanza is a promising area to conduct novel TB vaccine research prevention of infection (POI) studies targeting adolescents.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube.Clin Infect Dis. 2019 Oct 30;69(10):1724-1730. doi: 10.1093/cid/ciz034. Clin Infect Dis. 2019. PMID: 30668657 Free PMC article.
-
Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.J Microbiol Immunol Infect. 2016 Oct;49(5):729-736. doi: 10.1016/j.jmii.2014.08.010. Epub 2014 Nov 1. J Microbiol Immunol Infect. 2016. PMID: 25442858
-
Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.Health Technol Assess. 2018 Oct;22(56):1-96. doi: 10.3310/hta22560. Health Technol Assess. 2018. PMID: 30334521 Free PMC article.
-
[Evolution of IGRA researches].Kekkaku. 2008 Sep;83(9):641-52. Kekkaku. 2008. PMID: 18979999 Review. Japanese.
-
Fourth-Generation QuantiFERON-TB Gold Plus: What Is the Evidence?J Clin Microbiol. 2020 Aug 24;58(9):e01950-19. doi: 10.1128/JCM.01950-19. Print 2020 Aug 24. J Clin Microbiol. 2020. PMID: 32493779 Free PMC article. Review.
Cited by
-
Aqueous extract-mediated green synthesis of CuO nanoparticles: Potential anti-tuberculosis agents.Food Sci Nutr. 2024 May 30;12(8):5907-5921. doi: 10.1002/fsn3.4227. eCollection 2024 Aug. Food Sci Nutr. 2024. PMID: 39139956 Free PMC article.
-
Airborne transmission risks of tuberculosis and COVID-19 in schools in South Africa, Switzerland, and Tanzania: Modeling of environmental data.PLOS Glob Public Health. 2024 Jan 18;4(1):e0002800. doi: 10.1371/journal.pgph.0002800. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 38236801 Free PMC article.
-
Recent Advances in Nanotechnology-Based Strategies for Bone Tuberculosis Management.Pharmaceuticals (Basel). 2024 Jan 29;17(2):170. doi: 10.3390/ph17020170. Pharmaceuticals (Basel). 2024. PMID: 38399384 Free PMC article. Review.
-
Prevalence and Predictors of Tuberculosis Infection in Children and Adolescents in Rural Uganda: A Cross-sectional Study.Pediatr Infect Dis J. 2024 Dec 1;43(12):1120-1127. doi: 10.1097/INF.0000000000004475. Epub 2024 Jul 15. Pediatr Infect Dis J. 2024. PMID: 39018476
-
Latent tuberculosis in children and youth with type 1 diabetes mellitus in Dar es Salaam, Tanzania: a cross section survey.BMC Infect Dis. 2023 Oct 30;23(1):740. doi: 10.1186/s12879-023-08753-4. BMC Infect Dis. 2023. PMID: 37904143 Free PMC article.
References
-
- Global tuberculosis report 2020. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO
-
- The Stop TB Partnership. 12 months of COVID-19 eliminated 12 years of progress in the global fight against tuberculosis. March 18, 2021. http://www.stoptb.org/news/stories/2021/ns21_011.html.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources